» Articles » PMID: 36013601

The Effects of , , , , and Decoction on a Dry Eye Mouse Model

Overview
Publisher MDPI
Specialty General Medicine
Date 2022 Aug 26
PMID 36013601
Authors
Affiliations
Soon will be listed here.
Abstract

: Dry eye disease (DED) is a relatively common disorder associated with abnormal tear film and the ocular surface that causes ocular irritation, dryness, visual impairment, and damage to the cornea. DED is not a life-threatening disease but causes discomfort and multifactorial disorders in vision that affect daily life. It has been reported that all traditional medicinal plants exhibit anti-inflammatory effects on several diseases. We hypothesized that the decoction ameliorated ocular irritation and decreased cytokine expression in the cornea. This study aimed to investigate the molecular mechanisms of DED and discover a therapeutic strategy to reduce corneal inflammation. : We used a DED mouse model with extraorbital lacrimal gland (ELG) excision and treated the mice with a decoction of five traditional medicines: , , , , and for 3 months. The tear osmolarity and the ocular surface staining were evaluated as indicators of DED. Immunohistochemistry was used to detect the level of inflammation on the cornea. : After treatment with the decoction for three months, epithelial erosions and desquamation were reduced, the intact of corneal endothelium was maintained, and tear osmolarity was restored in the eyes. The IL-1β-associated inflammatory response was reduced in the cornea in the DED model. These data suggested that a mixture of traditional medicines might be a novel therapy to treat DED.

Citing Articles

Run-Mu-Ling Granules Mitigate Ocular Surface Inflammatory Injury Associated with Dry Eye by Suppressing the NLRP3/GSDMD-Mediated Pyroptosis Pathway.

Luo D, Ji H, Yan X, Wang Z, Li L, Shi L J Inflamm Res. 2024; 17:10769-10784.

PMID: 39677285 PMC: 11645896. DOI: 10.2147/JIR.S496231.

References
1.
Shinomiya K, Ueta M, Kinoshita S . A new dry eye mouse model produced by exorbital and intraorbital lacrimal gland excision. Sci Rep. 2018; 8(1):1483. PMC: 5784089. DOI: 10.1038/s41598-018-19578-6. View

2.
Holzchuh R, Albers M, Osaki T, Igami T, Santo R, Kara-Jose N . Two-year outcome of partial lacrimal punctal occlusion in the management of dry eye related to Sjögren syndrome. Curr Eye Res. 2011; 36(6):507-12. DOI: 10.3109/02713683.2011.569870. View

3.
Li D, Zheng C, Zhang F, Shi J . Potential neuroprotection by nobile Lindl alkaloid in Alzheimer's disease models. Neural Regen Res. 2021; 17(5):972-977. PMC: 8552836. DOI: 10.4103/1673-5374.324824. View

4.
Slater B, Vilson F, Guo Y, Weinreich D, Hwang S, Bernstein S . Optic nerve inflammation and demyelination in a rodent model of nonarteritic anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2013; 54(13):7952-61. PMC: 3854773. DOI: 10.1167/iovs.13-12064. View

5.
Wu I, Chan S, Lin C . The neuroprotective effect of submicron and blended Lycium barbarum for experiment retinal ischemia and reperfusion injury in rats. J Vet Med Sci. 2020; 82(11):1719-1728. PMC: 7719877. DOI: 10.1292/jvms.19-0646. View